QuidelOrtho layoffs, on the record
Every job cut, severance charge and restructuring QuidelOrtho reported in its annual reports, 2023 to 2025, quoted from the filings. Headcount went from approximately 7,100 to approximately 6,500.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 10-K for 2023 | approximately 7,100 | December 31, 2023 |
| 10-K for 2024 | approximately 6,600 | December 29, 2024 |
| 10-K for 2025 | approximately 6,500 | December 28, 2025 |
Job cuts, severance and restructuring
Our summaryThe company launched a multi-year, enterprise-wide cost-reduction and productivity program called the Optimization Plan, with about $100 million of pre-tax charges expected through 2027.
Word for word“In the second quarter of 2025, we launched multi-year, enterprise-wide cost-reduction, strategic productivity and margin improvement initiatives (the “Optimization Plan”) that aim to (i) realign our costs with our long-term revenue expectations, (ii) drive operational efficiencies in manufacturing and distribution cost bases and (iii) support and align with our strategy to invest in key priorities.” 10-K for 2025
Our summaryThe company announced a strategic refocusing of its Molecular Diagnostics business, including ending development of the SAVANNA platform, which it expects to finish by the first half of 2027.
Word for word“Additionally, in the second quarter of 2025, we announced a strategic refocusing of our Molecular Diagnostics business, including our plan to discontinue the development of the SAVANNA platform, which exit we expect to be substantially complete by the first half of 2027, and our intent to acquire LEX Diagnostics.” 10-K for 2025
| Fiscal year ended | Cash paid for restructuring |
|---|---|
| 2025-12-28 | $400,000 |
QuidelOrtho has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from QuidelOrtho’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-19. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.